OTCMKTS:ASNB

EKIMAS (ASNB) Stock Price, News & Analysis

$0.61
0.00 (0.00%)
(As of 04/25/2024 ET)
Today's Range
$0.61
$0.61
50-Day Range
$0.45
$0.61
52-Week Range
$0.55
$1.75
Volume
N/A
Average Volume
3,162 shs
Market Capitalization
$3.54 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

About EKIMAS

EKIMAS Corp. engages in the development of polymer materials, which provide characteristics in the design and development of medical devices. Its biomaterials are used in devices that are designed for treating a range of anatomical sites and disease states. The firm's products include ChronoFlex, ChronoSil, HydroMed, HydroThane, and PolyBlend. The company was founded in 1993 and is headquartered in Las Vegas, NV.

ASNB Stock Price History

ASNB Stock News Headlines

Claim Your Complimentary Bitcoin Reward
Many have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.
EKIMAS Corporation (ASNB)
See More Headlines
Receive ASNB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for EKIMAS and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
10/16/2014
Today
4/26/2024
Fiscal Year End
3/31/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
N/A
Current Symbol
OTCMKTS:ASNB
Employees
11
Year Founded
N/A

Profitability

Net Income
$-290,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$0.03 per share

Miscellaneous

Free Float
5,347,000
Market Cap
$3.54 million
Optionable
Not Optionable
Beta
0.37
10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

  • Henrik Rouf
    Chief Executive Officer
  • Bennett J. Yankowitz
    Chief Financial Officer & Director

ASNB Stock Analysis - Frequently Asked Questions

How have ASNB shares performed in 2024?

EKIMAS's stock was trading at $0.62 at the start of the year. Since then, ASNB shares have decreased by 1.6% and is now trading at $0.61.
View the best growth stocks for 2024 here
.

How were EKIMAS's earnings last quarter?

EKIMAS Co. (OTCMKTS:ASNB) issued its quarterly earnings data on Thursday, October, 16th. The company reported $0.31 EPS for the quarter, topping the consensus estimate of $0.29 by $0.02. During the same quarter in the previous year, the business earned $0.27 earnings per share.

What other stocks do shareholders of EKIMAS own?

Based on aggregate information from My MarketBeat watchlists, some companies that other EKIMAS investors own include NVIDIA (NVDA), Associated Banc (ASB), PermRock Royalty Trust (PRT), CytoDyn (CYDY), FuelCell Energy (FCEL), Interpace Biosciences (IDXG), Sphere 3D (ANY), AVEO Pharmaceuticals (AVEO), Boeing (BA) and Bank of America (BAC).

How do I buy shares of EKIMAS?

Shares of ASNB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:ASNB) was last updated on 4/26/2024 by MarketBeat.com Staff

From Our Partners